BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 723351)

  • 1. [Regional hyperthermic perfusion in malignant melanoma of the extremities--controlled studies (proceedings)].
    Hafström L; Jönsson PE
    Lakartidningen; 1978 Dec; 75(49):4599-600. PubMed ID: 723351
    [No Abstract]   [Full Text] [Related]  

  • 2. [Various aspects of treatment of primary melanoblastoma of the extremities by regional perfusion].
    Schraffordt Koops H; Eibergen R; Oldhoff J; van der Ploegen E; Vermey A
    Ned Tijdschr Geneeskd; 1975 Nov; 119(45):1746-53. PubMed ID: 1214883
    [No Abstract]   [Full Text] [Related]  

  • 3. [Randomized melanoma study of perfusion of the extremities. Results of treatment 2 1/2 years after premature discontinuation].
    Ghussen F; Krüger I; Groth W; Stützer H
    Chirurg; 1986 Oct; 57(10):619-23. PubMed ID: 3539548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined treatment of malignant tumors of the extremities. Regional perfusion chemotherapy].
    Kolessov VI; Levin AO
    Minerva Med; 1970 Sep; 61(71):3673-5. PubMed ID: 4989391
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of perfusion and infusion in the treatment of malignant melanoma of the lower extremities].
    Meyza J
    Pediatr Pol; 1986 Aug; 61(8):521-3. PubMed ID: 3575001
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolated regional limb hyperthermic perfusion as treatment for melanoma.
    Loescher LJ; Leigh S
    Cancer Nurs; 1984 Dec; 7(6):461-7. PubMed ID: 6568866
    [No Abstract]   [Full Text] [Related]  

  • 7. [Regional hyperthermic perfusion with cytostatic agents in malignant melanoma of the extremities (author's transl)].
    Ghussen F; Nagel K; Groth W
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1612-5. PubMed ID: 7308000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperthermic chemotherapeutic isolation perfusion in malignant melanoma. Presentation of a case].
    Pettavel J; Hardmeier T; Hessler C
    Schweiz Med Wochenschr; 1970 Aug; 100(33):1425-8. PubMed ID: 5525035
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperthermic isolated limb perfusion with tumor necrosis factor is a useful therapy for advanced melanoma of the limbs.
    Lejeune FJ; Eggermont AM
    J Clin Oncol; 2007 Apr; 25(11):1449-50; author reply 1450-1. PubMed ID: 17416870
    [No Abstract]   [Full Text] [Related]  

  • 10. Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.
    Vrouenraets BC; Eggermont AM; Hart AA; Klaase JM; van Geel AN; Nieweg OE; Kroon BB
    Eur J Surg Oncol; 2001 Jun; 27(4):390-5. PubMed ID: 11417986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas].
    Tonak J; Hohenberger W; Göhl J
    Chirurg; 1984 Aug; 55(8):499-504. PubMed ID: 6488994
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].
    Kroon BB; Schraffordt Koops H
    Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2042-7. PubMed ID: 2234177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
    Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
    Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regional chemotherapy of malignant melanoblastomas of the extremities].
    Datsenko BM; Kutsyĭ AS
    Vopr Onkol; 1970; 16(1):22-30. PubMed ID: 4907676
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the morphologic changes in malignant melanomas of the skin during therapy using the method of regional perfusion with chemical preparations].
    Abbasov AT; Parshikova SM
    Arkh Patol; 1966; 28(11):42-5. PubMed ID: 6002050
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical results of extremity perfusion in malignant melanoma].
    Huber R; Stützer H; Krüger I
    Zentralbl Chir; 1996; 121(3):234-42. PubMed ID: 8867351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
    Kettelhack C; Hohenberger P; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():127-9. PubMed ID: 9101810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective therapy: repeat limb perfusion for recurrent melanoma.
    Krementz ET
    J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperthermic perfusion of recurrent malignant melanoma on the extremities.
    Hafström L; Jönsson PE
    Acta Chir Scand; 1980; 146(5):313-8. PubMed ID: 7468061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extensive lymphadenectomy and perfusion chemotherapy in the treatment of pigmented skin tumors of the lower extremities].
    Kolesov VI; Levin AO; Martyniuk VV; Sidorenko LN; Stepanova NS
    Vestn Khir Im I I Grek; 1970 Jun; 104(6):68-73. PubMed ID: 4992349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.